Feed / REPL

Replimune Group, Inc.

REPL

Healthcare · 14.58 +46.7% today

Isolated · not yet confirmedMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Replimune Group, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 5 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Company+46.7% todayVolume comparison unavailable
Market group0 of 5 activeBiotech and Insurance · unavailable
Disclosed network0 of 5 confirmingNo filing-linked name is confirming now
What would change this read
  • REPL's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if REPL's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind REPL

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BMYBristol-Myers Squibb CompanypartnerJun 29, 2026

Our leading clinical trial of RP1 is referred to as the IGNYTE trial, which is a multi-cohort clinical trial being conducted in collaboration with Bristol Myers Squibb Company, or BMS, under which BMS has granted us a non-exclusive, royalty-free license to, a…

HTGCHercules Capital, Inc.lenderJun 29, 2026

Interest expense on debt obligations Interest expense on debt obligations consists of the amortization of debt discount and cash paid for interest under the Hercules Loan Agreement.

Depended on by

CADLCandel Therapeutics, Inc.competitorMar 12, 2026

We are aware that Replimune Group, Inc., Amgen Inc., Astellas Pharma, Inc, Istari Oncology Inc, Orca Therapeutics, B.V., CG Oncology, Inc, ImmVira Co., Ltd., IconOVir Bio, Inc., and FerGene, Inc., among others, are developing viral immunotherapies that may ha…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

REPL is currently a Early Follower in the organic co-movement group Biotech and Insurance. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for REPL; it is not active in the latest market snapshot.